AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Daito Pharmaceutical Co., Ltd.
  3. Financials
  4. Free cash flow

Daito Pharmaceutical Co., Ltd.【JP:4577】

Market cap
¥43.5B
P/E ratio
18.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndFree cash flow (Million JPY)YoY (%)
May 31, 2025-892-14.07%
May 31, 2024-1,038-23.11%
May 31, 2023-1,350+425.29%
May 31, 2022-257-77.38%
May 31, 2021-1,136-172.12%
May 31, 20201,575-51.65%
May 31, 20193,258+98.26%
May 31, 20181,643-20.90%
May 31, 20172,078-307.81%
May 31, 2016-1,000-15.26%
May 31, 2015-1,180

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)